Loading…
Quick answer: Recombinant Bovine Somatotropin carries the heavier risk profile. Recombinant Bovine Somatotropin is — in the EU and — in the US; Retinyl palmitate is restricted in the EU and allowed in the US.
| Property | Recombinant Bovine Somatotropin | Retinyl palmitate |
|---|---|---|
| EU status | — | Restricted |
| US status | — | Allowed |
| Risk level | — | medium |
| Banned in | European Union, Canada, Japan, Australia, New Zealand | — |
| Restricted in | — | European Union |
| Category | additive | endocrine disruptor |
| Where it hides | — | anti-aging cream, sunscreen, lotion |
Recombinant bovine somatotropin (rBST) is the synthetic version of bovine growth hormone (BST), naturally produced by the pituitary gland in cattle. The recombinant version is produced using genetically engineered bacteria and is injected into dairy cows to increase milk production by 10-15%. Brand name: Posilac.
Retinyl palmitate is a vitamin A ester used in anti-aging skincare and sunscreen.
Recombinant Bovine Somatotropin: See recombinant-bovine-growth-hormone-rbgh for full detail. Key concerns: rBST elevates IGF-1 in milk; elevated blood IGF-1 is associated with breast, prostate, and colorectal cancer risk in epidemiological studies. Animal welfare: increased mastitis (up to 25-50% higher rates), lameness, and antibiotic use. The Codex Alimentarius Commission declined to endorse rBST safety MRLs in a historic 33-29 vote. Health Canada rejected rBST approval in 1999 after finding it caused significant animal health problems requiring increased antibiotic use.
Retinyl palmitate: The EU caps vitamin A levels over concerns it may accelerate skin damage in sunlight; the US does not restrict it.
Scan a barcode and we'll flag both Recombinant Bovine Somatotropin and Retinyl palmitate (plus 200+ other ingredients banned overseas).
Scan free →